Ns. Taylor et al., LONG-TERM COLONIZATION WITH SINGLE AND MULTIPLE STRAINS OF HELICOBACTER-PYLORI ASSESSED BY DNA-FINGERPRINTING, Journal of clinical microbiology, 33(4), 1995, pp. 918-923
The gastric pathogen Helicobacter pylori establishes long-term chronic
infections that can lead to gastritis, peptic ulcers, and cancer. The
species is so diverse that distinctly different strains are generally
recovered from each patient. To better understand the dynamics of lon
g-term carriage, we characterized H. pylori isolates from initial and
follow-up biopsy specimens from a patient population at high risk of H
. pylori infection and gastric cancer. Eighty-five isolates were obtai
ned from 23 patients and were analyzed by genomic restriction enzyme a
nalysis, arbitrarily primed PCR fingerprinting, (random amplified poly
morphic DNA analysis), and/or restriction of specific PCR-amplified ge
nes (restriction fragment length polymorphism analysis). A single stra
in was found in sequential biopsy specimens from 12 of 15 patients (80
%) receiving sucralfate. In the remaining three patients treated with
sucralfate, two strains were identified in two patients and three stra
ins were identified in the third patient. In contrast, a single strain
was found in sequential biopsy specimens from only three of eight pat
ients (37%) receiving bismuth, metronidazole, and nitrofurantoin. Two
strains were identified in five other patients receiving bismuth-antib
iotic (63%). Immunoglobulin G antibodies to H. pylori were present in
the sera of all patients. Thus, H. pylori colonization can persist for
long periods (up to at least 4 years), despite high titers of immunog
lobulin G antibodies in serum. Resistance to metronidazole was noted i
n some strains before and/or after treatment, but all strains remained
susceptible to amoxicillin, tetracycline, and nitrofurantoin. We conc
lude that H. pylori genotypes, as measured by several sensitive DNA fi
ngerprinting methods, can remain stable for years in vivo, despite the
acquisition or loss of drug resistance, circulating antibody, or expo
sure to antibiotics or sucralfate.